Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer
Phase 2 Completed
41 enrolled 9 charts
EMEG-ECDD
Phase NA Completed
97 enrolled
Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
Phase 2 Completed
29 enrolled 15 charts
PRIMED
Phase 2 Completed
50 enrolled
A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy
Phase 4 Completed
233 enrolled
Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated
Completed
57,725 enrolled
Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
Phase 1 Completed
15 enrolled
Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
Phase 1 Completed
50 enrolled
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
Phase 3 Completed
224 enrolled
A Study of LY2523355 in Participants With Breast Cancer
Phase 2 Completed
39 enrolled 16 charts
Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer
Phase 2 Completed
68 enrolled 10 charts
Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer
Phase 3 Completed
184 enrolled
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
Phase 2 Completed
50 enrolled 13 charts
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery
Phase 2 Completed
60 enrolled 11 charts
Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)
Phase 3 Completed
60 enrolled
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer
Phase 2 Completed
60 enrolled 17 charts
Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients
Phase 3 Completed
135 enrolled 18 charts
PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy
Phase 4 Completed
215 enrolled
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
Phase 1 Completed
33 enrolled
PIONEER
Phase 3 Completed
218 enrolled 15 charts
Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer
Phase 1 Completed
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
Phase 3 Completed
180 enrolled
Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
Phase 2 Completed
226 enrolled 8 charts
Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer
Phase 1 Completed
26 enrolled
Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
Phase 3 Completed
600 enrolled
Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer
Phase 3 Completed
1,856 enrolled
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer
Phase 2 Completed
40 enrolled
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
Phase 1 Completed
30 enrolled
Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer
Phase 2 Completed
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
Phase 2 Completed
76 enrolled 6 charts
Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer
Phase 2 Completed
62 enrolled
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
Phase 2 Completed
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
Phase 2 Completed
Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer
Phase 1 Completed
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
Phase 1/2 Completed
25 enrolled
15-95
Phase 3 Completed
344 enrolled
Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
Phase 2 Completed
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Phase 2 Completed
39 enrolled
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Phase 3 Completed
399 enrolled
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
Phase 2 Completed
170 enrolled 23 charts
Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes
Phase 2 Completed
16 enrolled
Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
Phase 2 Completed
45 enrolled
High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
Phase 1/2 Completed
21 enrolled
Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
Phase 2 Completed
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
Phase 1/2 Completed
High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
Phase 2 Completed
61 enrolled
Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer
Phase 1/2 Completed
15 enrolled
G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer
Phase 2 Completed
120 enrolled
Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
Phase 2 Completed
40 enrolled